Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Selected Articles from This Issue

DOI:  Published December 2020
  • Article
  • Info & Metrics
  • PDF
Loading

Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States

Islam et al. Page 2583

The COVID-19 pandemic continues to impact the continuity of care and behaviors of cancer survivors in the United States. Islam and colleagues leveraged the nationally representative COVID Impact Survey to examine COVID-19 preventive behaviors among cancer survivors, specifically practices related to canceling doctor's appointments. Cancer survivors were more likely to cancel doctor's appointments than other U.S. adults, as recently as June 2020. While non-Hispanic Black cancer survivors were less likely to cancel a doctor's appointment, cancer survivors aged 18 to 29, women, and those with at least one comorbid condition were more likely. Women who reported that their plans were impacted by school/childcare closures were more likely to cancel their doctor's appointments. These findings have implications for engagement in cancer survivorship care and treatment during the COVID-19 pandemic.

Premature Years of Life Lost Due to Cancer in the United States in 2017

Song et al. Page 2591

It is important to consider the number of deaths and also the age at deaths when quantifying cancer burden. Song and colleagues estimated the impact of cancer on premature deaths by potential years of life lost (PYLL) and PYLL per death in the United States. In 2017, the largest number of PYLLs were due to lung/bronchus, colon/rectum, and breast cancers, whereas the largest number of PYLLs per death were due to testicular cancers. Mortality rates, PYLL, and PYLL per death are complementary measures of the cancer burden that should be considered in tandem to prioritize public health interventions focused on preventing premature mortality.

HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening

Rohner et al. Page 2651

Primary human papillomavirus (HPV) testing of self-collected cervico-vaginal samples could increase cervical cancer screening coverage, and extended HPV genotyping may serve as a triage strategy for colposcopy follow-up. Rohner and colleagues found that individual HPV type–specific agreement between self- and provider-collected samples ranged from substantial to almost perfect. HPV-16 was most predictive of high-grade cervical cancer detection in self- and provider-collected samples. However, HPV-16 was detected more frequently in self-collected (27%) than provider-collected specimens (20%), which may result in higher colposcopy referral rates based on self-collected samples. Additional molecular biomarkers may improve the triage of women who are HPV positive.

Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population

Bogumil et al. Page 2686

This is the first study to examine the association of previously identified risk loci with pancreatic cancer risk in an ethnically diverse population from the Multiethnic Cohort Study and the Southern Community Cohort Study. Bogumil and colleagues found 11 of 31 risk loci to be associated with pancreatic cancer in the multiethnic sample. A weighted polygenic risk score, using all variants, was associated with pancreatic cancer in the combined sample and within most ethnic groups. This study shows the utility of multiple risk loci in predicting pancreatic cancer risk in a multiethnic population.

  • ©2020 American Association for Cancer Research.
Next
Back to top
Cancer Epidemiology Biomarkers & Prevention: 29 (12)
December 2020
Volume 29, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Selected Articles from This Issue
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Selected Articles from This Issue
Cancer Epidemiol Biomarkers Prev December 1 2020 (29) (12) 2387;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Selected Articles from This Issue
Cancer Epidemiol Biomarkers Prev December 1 2020 (29) (12) 2387;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States
    • Premature Years of Life Lost Due to Cancer in the United States in 2017
    • HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening
    • Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement